Corcept Therapeutics Incorporated CORT
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Joon Lee | Truist Financial | 70.74 $ | 135 $ | 64.26 % | 06/05/2025 |
| Swayampakula Ramakanth | H.C. Wainwright | 73.94 $ | 145 $ | 71.06 % | 06/05/2025 |
| Swayampakula Ramakanth | H.C. Wainwright | 47.17 $ | 80 $ | 32.83 % | 18/10/2024 |
| Joon Lee | Truist Financial | 43.93 $ | 76 $ | 32.07 % | 30/09/2024 |
| Edward Nash | Canaccord Genuity | 34.71 $ | 78 $ | 43.29 % | 15/08/2024 |
| David Amsellem | Piper Sandler | 36.12 $ | 38 $ | 1.88 % | 30/07/2024 |
| Swayampakula Ramakanth | H.C. Wainwright | 36.53 $ | 45 $ | 8.47 % | 30/07/2024 |
| Edward Nash | Canaccord Genuity | 32.79 $ | 38 $ | 5.21 % | 12/06/2024 |
| David Amsellem | Piper Sandler | 31.51 $ | 35 $ | 3.49 % | 10/06/2024 |
| Joon Lee | Truist Financial | 31.59 $ | 65 $ | 33.41 % | 04/06/2024 |
| Swayampakula Ramakanth | H.C. Wainwright | 23.88 $ | 40 $ | 16.12 % | 02/05/2024 |